Theravance Biopharma, Inc. (TBPH)
17.00
-0.01
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Market Cap : 882.15M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 882.67M |
| August 20, 2026 | 879.55M |
| August 19, 2026 | 881.63M |
| August 18, 2026 | 879.55M |
| August 17, 2026 | 878.00M |
| August 14, 2026 | 880.59M |
| August 13, 2026 | 878.00M |
| August 12, 2026 | 878.00M |
| August 11, 2026 | 878.00M |
| August 10, 2026 | 877.48M |
| August 07, 2026 | 878.51M |
| August 06, 2026 | 878.00M |
| August 05, 2026 | 876.95M |
| August 04, 2026 | 869.57M |
| August 03, 2026 | 869.06M |
| July 31, 2026 | 868.54M |
| July 30, 2026 | 868.03M |
| July 29, 2026 | 868.03M |
| July 28, 2026 | 870.09M |
| July 27, 2026 | 868.54M |
| July 24, 2026 | 868.54M |
| July 23, 2026 | 868.54M |
| July 22, 2026 | 865.97M |
| July 21, 2026 | 867.51M |
| July 20, 2026 | 865.97M |
| Date | Value |
|---|---|
| July 17, 2026 | 872.15M |
| July 16, 2026 | 874.21M |
| July 15, 2026 | 872.15M |
| July 14, 2026 | 871.63M |
| July 13, 2026 | 870.60M |
| July 10, 2026 | 872.15M |
| July 09, 2026 | 874.72M |
| July 08, 2026 | 875.76M |
| July 07, 2026 | 876.27M |
| July 06, 2026 | 875.76M |
| July 02, 2026 | 872.15M |
| July 01, 2026 | 874.72M |
| June 30, 2026 | 875.76M |
| June 29, 2026 | 878.85M |
| June 26, 2026 | 908.21M |
| June 25, 2026 | 895.85M |
| June 24, 2026 | 889.66M |
| June 23, 2026 | 874.21M |
| June 22, 2026 | 853.09M |
| June 18, 2026 | 854.12M |
| June 17, 2026 | 860.82M |
| June 16, 2026 | 859.79M |
| June 15, 2026 | 840.72M |
| June 12, 2026 | 857.21M |
| June 11, 2026 | 849.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zymeworks, Inc. | 2.070B |
| Viatris, Inc. | 19.11B |
| Ocular Therapeutix, Inc. | 2.368B |
| ANI Pharmaceuticals, Inc. | 1.705B |
| Corcept Therapeutics, Inc. | 13.30B |
Market Cap Related Metrics
| PE Ratio | 16.84 |
| PS Ratio | 8.471 |
| PEG Ratio | 0.0509 |
| Price to Book Value | 3.045 |
| Price to Free Cash Flow | 16.44 |
| Price | 17.00 |
| Earnings Yield | 5.94% |
| PEGY Ratio | 0.0509 |
| Operating PE Ratio | 400.00 |
| Normalized PE Ratio | 14.21 |